# A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

> clinical trial · VERIFIED · 2026-06-12

Status: ENROLLING_BY_INVITATION · Sponsor: UCB Biopharma SRL · Condition: Systemic Lupus Erythematosus

- Company: UCB Biopharma SRL
- Sector: immunology
- Primary source: https://clinicaltrials.gov/study/NCT04976322

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.